Nearly 250 NAION cases sit in Pennsylvania federal court with hundreds more in New Jersey. Relkin, co-lead counsel, points to a baseline eye exam before starting a GLP-1.
Recap by typeshit. Full story at Drugwatch.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Trefis says investors are watching whether MariTide's vomiting rate lands in the mid-20s or lower. Amgen also dropped an early obesity drug, AMG 513.
A general rundown of how the two drugs work, who might benefit and what to know before starting, with no new findings or news.
Loading…